EXACT Therapeutics AS — Director's Dealing 2021

Dec 5, 2021

1	Details of the Primary Insider/Close Associate
a)	Name	Andrew J. Healy
2	Reason for the notification
a)	Position/status	The notification concerns
		a Primary insider: CSO, Andrew J. Healy
b)	Initial notification/	Initial notification
	Amendment
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or
	auction monitor
a)	Name	EXACT Therapeutics AS
b)	LEI	2138006ZE5JAL39AGD55
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
		type of transaction; (iii) each date; and (iv) each place where transactions have been
	conducted
a)	Description of the	Nature of the instrument: Share
	financial instrument, type
	of instrument	Instrument of identification code (ISIN): NO 001 0852213
	Identification code
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 17.1806 per share	886
d)	Aggregated information	Price: NOK 15 222
	- Aggregated volume	Volume: 886
	- Price
e)	Date of the transaction	2021-12-03
f)	Place of the transaction	MERK – Oslo Børs